| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +33.33% | -3.80% | +0.83% | -4.63% | +0.54% | — |
| 14d | 3 | +0.00% | +0.49% | +0.91% | -0.42% | -4.19% | — |
| 30d | 3 | +0.00% | +4.87% | -3.44% | +8.31% | -0.65% | — |
| 60d | 3 | +33.33% | +13.25% | +2.17% | +11.08% | +0.76% | — |
| 90d | 3 | +33.33% | +6.03% | +3.84% | +2.19% | -0.06% | — |
| 180d | 3 | +33.33% | -2.15% | +7.76% | -9.91% | -10.42% | — |
| 1y | 3(1 pending) | +50.00% | -1.90% | +17.13% | -19.02% | -19.02% | — |
| 2y | 3(2 pending) | +0.00% | -64.96% | +52.89% | -117.85% | -117.85% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ACHV ACHIEVE LIFE SCIENCES, INC. | PURCHASEGRANT Stock grant | 180,000 | — | — | 180,000 | Jan 28, 2026 | Jan 30, 2025 ↗ | View → |
| ACHV ACHIEVE LIFE SCIENCES, INC. | SALE Chief Financial Officer | 50,060 | $2.92 | $146.2K | 127,940 | Sep 18, 2025 | Sep 22, 2025 ↗ | View → |
| ACHV ACHIEVE LIFE SCIENCES, INC. | PURCHASE Chief Financial Officer | 168,000 | — | — | 178,000 | Sep 18, 2025 | Sep 22, 2025 ↗ | View → |
| ACHV ACHIEVE LIFE SCIENCES, INC. | SALE Chief Financial Officer | 168,000 | — | — | 0 | Sep 18, 2025 | Sep 22, 2025 ↗ | View → |
| ACHV ACHIEVE LIFE SCIENCES, INC. | SALEGRANT Stock grant | 168,000 | — | — | 0 | Sep 4, 2025 | Sep 8, 2025 ↗ | View → |
| ACHV ACHIEVE LIFE SCIENCES, INC. | PURCHASE Chief Financial Officer | 10,000 | $2.89 | $28.9K | 10,000 | Mar 17, 2025 | Mar 19, 2025 ↗ | View → |
| ACHV ACHIEVE LIFE SCIENCES, INC. | PURCHASEGRANT Stock grant | 168,000 | — | — | 168,000 | Dec 6, 2024 | Dec 9, 2024 ↗ | View → |
| ACHV ACHIEVE LIFE SCIENCES, INC. | PURCHASEGRANT Stock grant | 72,000 | — | — | 72,000 | Dec 6, 2024 | Dec 9, 2024 ↗ | View → |
| AYTU AYTU BIOPHARMA, INC | PURCHASEGRANT Stock grant | 13,000 | — | — | 13,000 | Aug 11, 2023 | Aug 15, 2023 ↗ | View → |
| AYTU AYTU BIOPHARMA, INC | PURCHASEGRANT Stock grant | 90,000 | $0.23 | $20.7K | 190,000 | Nov 18, 2022 | Nov 21, 2022 ↗ | View → |
| AYTU AYTU BIOPHARMA, INC | PURCHASE Chief Financial Officer | 90,000 | $0.23 | $20.7K | 190,000 | Nov 18, 2022 | Nov 28, 2022 ↗ | View → |
| AYTU AYTU BIOPHARMA, INC | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Jan 17, 2022 | Jan 18, 2022 ↗ | View → |